Chronic Fluoxetine Treatment Increases the Expression of PSA-NCAM in the Medial Prefrontal Cortex
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Recent hypotheses suggest that changes in neuronal structure and connectivity may underlie the etiology of depression. The medial prefrontal cortex (mPFC) is affected by depression and shows neuronal remodeling during adulthood. This plasticity may be mediated by the polysialylated form of the neural cell adhesion molecule (PSA-NCAM), which is intensely expressed in the adult mPFC. As the expression of PSA-NCAM is increased by serotonin in other cerebral regions, antidepressants acting on serotonin reuptake may influence PSA-NCAM expression and thus counteract the effects of depression by modulating neuronal structural plasticity. Using immunohistochemistry, we have studied the relationship between serotoninergic fibers and PSA-NCAM expressing neurons in the adult rat mPFC and the expression of serotonin receptors in these cells. The effects of fluoxetine treatment for 14 days on mPFC PSA-NCAM expression have also been analyzed. Although serotoninergic fibers usually do not contact PSA-NCAM immunoreactive neurons, most of these cells express 5-HT3 receptors. In general, chronic fluoxetine treatment induces significant increases in the number of PSA-NCAM immunoreactive neurons and in neuropil immunostaining and coadministration of the 5-HT3 antagonist ondansetron blocks the effects of fluoxetine on PSA-NCAM expression. These results indicate that fluoxetine, acting through 5-HT3 receptors, can modulate PSA-NCAM expression in the mPFC. This modulation may mediate the structural…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, 5-HT is linked to cell adhesion molecules (Lesch and Waider, 2012), which are part of the extracellular matrix and crucial for developmental plasticity (Varea et al., 2007).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Varea et al., 2007
In the citing paper
“Fluoxetine was demonstrated to increase the expression of PSA-NCAM in the prefrontal cortex, and alter the structure connectivity and plasticity of cortical interneurons.(Guirado et al., 2014;Varea et al., 2007).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Varea et al., 2007
Citations
Cites
The efficiency of systematic sampling in stereology and its prediction*
Gundersen, H. J. G., & Jensen, E. B. (1987) · Journal of Microscopy · doi:10.1111/j.1365-2818.1987.tb02837.x · Cited by 3,520 · cited 1×
“The volume of the different areas analyzed was determined for each animal using the Cavalieri’s principle (Gundersen and Jensen, 1987).”
MethodSubgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · cited 2×
“Brain imaging studies have demonstrated a reduction in blood flow, volume, number of glial cells, and neurons in the prefrontal cortex of patients suffering depression (Drevets et al, 1997; Ongur et al, 1998; Rajkowska et al, 1999).”
BackgroundSteinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415 · cited 2×
“The mPFC receives a dense serotoninergic innervation (Azmitia and Segal, 1978; Steinbusch, 1981) and contains several 5-HT receptor subtypes (Pazos et al, 1985; Pazos and Palacios, 1985; Pompeiano et al, 1992).”
BackgroundAzmitia, E. C., & Segal, M. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,909 · cited 2×
“The mPFC receives a dense serotoninergic innervation (Azmitia and Segal, 1978; Steinbusch, 1981) and contains several 5-HT receptor subtypes (Pazos et al, 1985; Pazos and Palacios, 1985; Pompeiano et al, 1992).”
BackgroundPazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · cited 2×
“The mPFC receives a dense serotoninergic innervation (Azmitia and Segal, 1978; Steinbusch, 1981) and contains several 5-HT receptor subtypes (Pazos et al, 1985; Pazos and Palacios, 1985; Pompeiano et al, 1992).”
BackgroundMcEwen, B. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02950-4 · Cited by 1,827 · cited 2×
“Structural plastic processes, such as dendritic or spine remodeling, have been observed in several regions of the adult CNS, specially as a response to aversive experiences (McEwen, 2000), or as a consequence of several learning paradigms (Muller et al, 2002).”
BackgroundDifferential projections of the infralimbic and prelimbic cortex in the rat
Vertes, R. P. (2004) · Synapse · doi:10.1002/syn.10279 · Cited by 1,550 · cited 1×
“Moreover, the prefrontal cortex neurons project back to the brain nuclei that synthesize 5-HT, inducing its release (Jankowski and Sesack, 2004; Peyron et al, 1998; Takagishi and Chiba, 1991; Vertes, 2004).”
BackgroundGlial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 1×
“Brain imaging studies have demonstrated a reduction in blood flow, volume, number of glial cells, and neurons in the prefrontal cortex of patients suffering depression (Drevets et al, 1997; Ongur et al, 1998; Rajkowska et al, 1999).”
BackgroundRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 1×
“Brain imaging studies have demonstrated a reduction in blood flow, volume, number of glial cells, and neurons in the prefrontal cortex of patients suffering depression (Drevets et al, 1997; Ongur et al, 1998; Rajkowska et al, 1999).”
BackgroundThe cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182 · cited 1×
“In fact, antidepressant drugs may act by normalizing this impairment (Duman et al, 1999; Manji et al, 2000, 2001; Manji and Duman, 2001).”
Background
Cited by
How widespread is adult neurogenesis in mammals?
Gould, E. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2147 · Cited by 656
Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598
Polysialic acid in the plasticity of the developing and adult vertebrate nervous system
Rutishauser, U. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2285 · Cited by 584
Kraus, C., Castrén, E., Kasper, S., & Lanzenberger, R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.007 · Cited by 471
“Morever, 5-HT is linked to cell adhesion molecules (Lesch and Waider, 012), which are part of the extracellular matrix and crucial for evelopmental plasticity (Varea et al., 2007).”
BackgroundFluoxetine: a case history of its discovery and preclinical development
Perez-Caballero, L., Torres-Sanchez, S., Bravo, L., Mico, J. A., & Berrocoso, E. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.907790 · Cited by 178
“It is noteworthy that fluoxetine also increases synaptic plasticity, which might improve the reorganisation of neuronal circuits and induce a clinically beneficial effect [62,63].”
BackgroundTochigi, M., Iwamoto, K., Bundo, M., Sasaki, T., Kato, N., & Kato, T. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.10.010 · Cited by 172
Wainwright, S. R., & Galea, L. A. M. (2013) · Neural Plasticity · doi:10.1155/2013/805497 · Cited by 162
“[11, 116–119].”
Chronic stress alters inhibitory networks in the medial prefrontal cortex of adult mice
Gilabert-Juan, J., Castillo-Gomez, E., Guirado, R., Moltó, M. D., & Nacher, J. (2013) · Brain Structure and Function · doi:10.1007/s00429-012-0479-1 · Cited by 125
Self-citationCastrén, E., & Rantamäki, T. (2010) · CNS Drugs · doi:10.2165/11530010-000000000-00000 · Cited by 123
Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients
Varea, E., Guirado, R., Gilabert‐Juan, J., Martí, U., Castillo-Gómez, E., Blasco‐Ibáñez, J. M., Crespo, C., & Nácher, J. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.10.011 · Cited by 123
“…with decreases in SYN expression (Varea et al., 2007b) and parallel changes in the expression of both molecules have been observed in other brain regions after this treatment (Varea et al., 2007b) or after modulation of dopaminergic neurotransmission in the mPFC (Castillo-Gomez et al., 2008).”
BackgroundMethodResultSelf-citationReview: The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?
Rajkumar, R., & Mahesh, R. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109348161 · Cited by 116
“Recently a protein expression study showed that ondansetron (2mg/kg) blocked the facilitatory effects of fluoxetine on neuronal plasticity in the rat medial prefrontal cortex (Varea et al., 2007) suggesting that 5-HT3 receptor antagonists can mediate depression-like effects.”
BackgroundGilabert‐Juan, J., Varea, E., Guirado, R., Blasco‐Ibáñez, J. M., Crespo, C., & Nácher, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.09.032 · Cited by 115
Self-citationNCAM in Neuropsychiatric and Neurodegenerative Disorders
Brennaman, L. H., & Maness, P. F. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1170-4_19 · Cited by 114
Gilabert‐Juan, J., Castillo-Gómez, E., Pérez-Rando, M., Moltó, M. D., & Nácher, J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.07.009 · Cited by 110
Self-citationGuirado, R., Perez-Rando, M., Sanchez-Matarredona, D., Castrén, E., & Nacher, J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000406 · Cited by 103
“Indicating that an altered expression of PSA-NCAM, as that found after fluoxetine treatments (Varea et al., 2007a; Karpova et al., 2011; Guirado et al., 2012), might influence the structure of interneurons.”
BackgroundResultInfluentialSelf-citationOhira, K., Takeuchi, R., Iwanaga, T., & Miyakawa, T. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-43 · Cited by 96
“Consistently, the present study demonstrates that chronic FLX treatment increases the expression of polysialic acidneural cell adhesion molecule (PSA-NCAM), which is a marker for immature neurons and a regulator of neural plasticity [42,43], in the mFC, hippocampus, and amygdala; this is in agreement with previous fin…”
Xiong, K., Luo, D., Patrylo, P. R., Luo, X., Struble, R. G., Clough, R. W., & Yan, X. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.02.003 · Cited by 96
“…other molecules enriched in immature neurons, including polysialylated neural cell adhesion molecule (PSA-NCAM) and neuron-specific tubulin-III (TuJ1)([Seki and Arai, 1991], [Bonfanti et al., 1992], [O'Connell et al., 1997], [Fox et al., 2000], [Nacher et al., 2001] and [Varea et al., 2007a]).”
BackgroundZhang, X.-M. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.017.2009 · Cited by 96
“Certain antidepressants that modulate monoamine neurotransmission may infl uence the expression of DCX or PSA-NCAM in the hippocampus and prefrontal cortex (Sairanen et al., 2007; Varea et al., 2007; Perera et al., 2008).”
Gómez-Climent, M. Á., Guirado, R., Castillo-Gómez, E., Varea, E., Gutierrez-Mecinas, M., Gilabert-Juan, J., García-Mompó, C., Vidueira, S., Sanchez-Mataredona, D., Hernández, S., et al. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhq177 · Cited by 95
Self-citationPolysialic acid in brain development and synaptic plasticity
Hildebrandt, H., & Dityatev, A. (2013) · Topics in current chemistry · doi:10.1007/128_2013_446 · Cited by 94
“Strikingly, chronic antidepressant treatment with the selective serotonin reuptake inhibitor fluoxetine (prozac) increases polySia levels within the rat PFC [284-286] but also in other cortical areas [287].”
Krzywkowski, K., Davies, P. A., Feinberg‐Zadek, P. L., Bräuner‐Osborne, H., & Jensen, A. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708454105 · Cited by 93
Role of 5-HT3 Receptors in the Antidepressant Response
Betry, C., Etiévant, A., Oosterhof, C. A., Ebert, B., Sánchez, C., & Haddjeri, N. (2011) · Pharmaceuticals · doi:10.3390/ph4040603 · Cited by 90
Pérez-Cremades, D., Hernández, S., Blasco-Ibáñez, J. M., Crespo, C., Nacher, J., & Varea, E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0376-9 · Cited by 85
“In order to analyse the staining we used a previously described methodology (Varea et al. 2007).”
MethodSelf-citationFluoxetine Exerts Age-Dependent Effects on Behavior and Amygdala Neuroplasticity in the Rat
Homberg, J. R., Olivier, J. D. A., Blom, T., Arentsen, T., van Brunschot, C., Schipper, P., Korte-Bouws, G., van Luijtelaar, G., & Reneman, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016646 · Cited by 84
“In contrast to previous studies [25,26] we did not observe effects of chronic fluoxetine treatment on PSA-NCAM immunoreactivity in the mPFC.”
InfluentialNácher, J., Guirado, R., & Castillo-Gómez, E. (2013) · Neurochemical Research · doi:10.1007/s11064-013-0977-4 · Cited by 82
“At least in the mPFC, this action of fluoxetine appears to be mediated by 5HT3 receptors, which are expressed in PSANCAM expressing interneurons [92].”
Self-citationA Model for the Involvement of Neural Cell Adhesion Molecules in Stress-Related Mood Disorders
Sandi, C., & Bisaz, R. (2007) · Neuroendocrinology · doi:10.1159/000101535 · Cited by 75
Guirado, R., Sanchez-Matarredona, D., Varea, E., Crespo, C., Blasco-Ibáñez, J. M., & Nacher, J. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-5 · Cited by 70
“Pre-vious work in our laboratory demonstrated that 5HT, acting via 5HT3 receptors is able to regulate PSA-NCAM expression in the mPFC of adult rats [20].”
BackgroundMethodResultSelf-citationPinnock, S. B., Blake, A. M., Platt, N. J., & Herbert, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013652 · Cited by 68
Varea, E., Castillo-Gómez, E., Gómez‐Climent, M. Á., Blasco‐Ibáñez, J. M., Crespo, C., Martinez-Guijarro, F. J., & Nácher, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.01.001 · Cited by 68
Self-citationConboy, L., Tanrikut, C., Zoladz, P. R., Campbell, A. M., Park, C. R., Gabriel, C., Mocaer, E., Sandi, C., & Diamond, D. M. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009255 · Cited by 66
Gilabert‐Juan, J., Bellés, M., Sáez-Ibáñez, A. R., Carceller, H., Zamarbide-Forés, S., Moltó, M. D., & Nácher, J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.008 · Cited by 64
Self-citationAutomated analysis of images for molecular quantification in immunohistochemistry
Guirado, R., Carceller, H., Castillo-Gómez, E., Castrén, E., & Nacher, J. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00669 · Cited by 63
Self-citationDjordjevic, A. D., Djordjevic, J., Elaković, I., Adžić, M., Matić, G. M., & Radojcic, M. B. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.10.006 · Cited by 64
Pesarico, A. P., Bueno-Fernandez, C., Guirado, R., Gómez-Climent, M. Á., Curto, Y., Carceller, H., & Nacher, J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00197 · Cited by 62
Self-citationWainwright, S. R., Workman, J. L., Tehrani, A. R., Hamson, D. K., Chow, C., Lieblich, S. E., & Galea, L. A. M. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.01.001 · Cited by 60
Distribution of PSA-NCAM in normal, Alzheimer’s and Parkinson’s disease human brain
Murray, H. C., Low, V. F., Swanson, M. E. V., Dieriks, B. V., Turner, C. P., Faull, R. L. M., & Curtis, M. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.003 · Cited by 59
“We observed a laminar distribution of PSA-NCAM+ cells and processes similar to that described in the human medial prefrontal cortex (Varea et al., 2007b), rat medial prefrontal cortex (Varea et al., 2005) and cat cerebral cortex (Varea et al., 2011).”
InfluentialDiniz, C. R. A. F., Casarotto, P. C., Resstel, L., & Joca, S. R. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.04.001 · Cited by 58
Nácher, J., Guirado, R., Varea, E., Alonso‐Llosà, G., Röckle, I., & Hildebrandt, H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.067 · Cited by 58
Self-citationBisaz, R., Schachner, M., & Sandi, C. (2011) · Hippocampus · doi:10.1002/hipo.20723 · Cited by 56
“…stress can inhibit the levels of this neuroplasticity molecule (i.e., PSA-NCAM) in the PFC which, strikingly, it is the opposite effect to the one observed after chronic antidepressant treatments (i.e., enhancement of PSA-NCAM expression in the PFC) (Sairanen et al., 2007; Varea et al., 2007).”
BackgroundMuneoka, K. T., Shirayama, Y., Takigawa, M., & Shioda, S. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9818-2 · Cited by 49
Guirado, R., Varea, E., Castillo-Gómez, E., Gómez‐Climent, M. Á., Rovira-Esteban, L., Blasco‐Ibáñez, J. M., Crespo, C., Martinez-Guijarro, F. J., & Nácher, J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.104 · Cited by 48
Self-citationXu, Y., Li, S., Vernon, M. M., Pan, J., Chen, L., Barish, P. A., Zhang, Y., Acharya, A. P., Yu, J. Z., Govindarajan, S. S., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07356.x · Cited by 48
“The effect was similar to those observed for fluoxetine, which blocks the dendritic atrophy and spine loss induced by chronic stress or depression in the cerebral cortex (Varea et al. 2007; Bessa et al. 2009).”
ResultSong, T., Wu, H., Li, R., Xu, H., Rao, X., Gao, L., Zou, Y., & Lei, H. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.03.009 · Cited by 45
“These results are consistent with previous reports of weight loss and/or reduced body weight gain in the animals treated with Flx at similar doses [2,4,27].”
Castillo-Gómez, E., Gómez‐Climent, M. Á., Varea, E., Guirado, R., Blasco‐Ibáñez, J. M., Crespo, C., Martinez-Guijarro, F. J., & Nácher, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.07.018 · Cited by 45
“We have recently shown that similar neuronal plasticity mediates the effects of antidepressants acting on serotoninergic neurotransmission (Varea et al., 2007a, 2007b), providing a substrate to the neuroplastic hypothesis of depression (Castren, 2005; Duman, 2002).”
InfluentialSelf-citationCastillo-Gómez, E., Varea, E., Blasco-Ibáñez, J. M., Crespo, C., & Nacher, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029516 · Cited by 44
Self-citationAltered Distribution of Hippocampal Interneurons in the Murine down Syndrome Model Ts65Dn.
Hernández-González, S., Ballestín, R., López-Hidalgo, R., Gilabert-Juan, J., Blasco-Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1479-8 · Cited by 41
Self-citationThe Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap
Szechtman, H., Harvey, B. H., Woody, E. Z., & Hoffman, K. L. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017772 · Cited by 41
“Moreover, 5-HT is linked to cell adhesion molecules (Lesch and Waider, 2012), which are part of the extracellular matrix and crucial for developmental plasticity (Varea et al., 2007).”
BackgroundGilabert‐Juan, J., Bueno-Fernández, C., Castillo-Gómez, E., & Nácher, J. (2016) · Brain and Behavior · doi:10.1002/brb3.534 · Cited by 40
“…expressing GAD67- EGFP covering the total hippocampus and distinguishing by layers (oriens, lucidum, and radiatum) and regions (CA1 and CA3) was estimated using a modified version of the fractionator method (West et al., 1991), as described before (Varea et al., 2007; Castillo- Gómez et al., 2011).”
MethodSelf-citationThe Role of Natural Products in Treatment of Depressive Disorder
Noori, T., Sureda, A., Sobarzo-Sánchez, E., & Shirooie, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220103140834 · Cited by 39
“PSA-NCAM has a significant effect on synaptogenesis and neurite regeneration [92, 93].”
Cambon, K., Coura, R., Groc, L., Carbon, A., Weissmann, D., Changeux, J., Pujol, J. F., & Granon, S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.015 · Cited by 38
Gilabert‐Juan, J., Moltó, M. D., & Nácher, J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.073 · Cited by 36
“…GAD67 andNCAM), three sectionsper animal containing the 3 amygdaloid nuclei analyzed (CeM, BLa andMe) were selected randomly from the following coordinate interval: Bregma −1.80 to 2.80 mm (Paxinos and Watson, 1986), in order to measure immunoreactivity as previously described (Varea et al., 2007).”
InfluentialSelf-citationCastillo-Gómez, E., Coviello, S., Pérez-Rando, M., Curto, Y., Carceller, H., Salvador, A., & Nácher, J. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.06.002 · Cited by 35
Self-citationMcCall, T., Weil, Z. M., Nacher, J., Bloss, E. B., El Maarouf, A., Rutishauser, U., & McEwen, B. S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.028 · Cited by 34
“Antidepressant treatment by either fluoxetine or imipramine increases PSA-NCAM expression (Sairanen et al., 2007; Varea et al., 2007).”
Self-citationYachi, K., Inoue, K., Tanaka, H., Yoshikawa, H., & Tohyama, M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.024 · Cited by 33
Saini, V., Kaur, T., Kalotra, S., & Kaur, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105186 · Cited by 31
Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models
Xu, Y., Ma, L., Jiang, W., Li, Y., Wang, G., & Li, R. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00344 · Cited by 31
“For example, the 5-HT system in the PFC seemed to be associated with reward behavior and positive affections (Varea et al., 2007), while the roles of 5-HT and DA in HPC functions may involve emotional alterations and anti-depression (Robertson et al., 2005; Boldrini et al., 2012; Jiang et al.,…”
BackgroundEffects of fluoxetine on plasticity and apoptosis evoked by chronic stress in rat prefrontal cortex
Djordjevic, A. D., Djordjevic, J., Elaković, I., Adžić, M., Matić, G. M., & Radojcic, M. B. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.07.042 · Cited by 29
Chronic benzodiazepine treatment decreases spine density in cortical pyramidal neurons
Curto, Y., García-Mompó, C., Bueno-Fernández, C., & Nácher, J. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.048 · Cited by 29
Self-citationAre NCAM deficient mice an animal model for schizophrenia?
Albrecht, A., & Stork, O. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00043 · Cited by 26
Impact of stress on inhibitory neuronal circuits, our tribute to Bruce McEwen
Pérez-Rando, M., Carceller, H., Castillo-Gómez, E., Bueno-Fernández, C., García-Mompó, C., Gilabert‐Juan, J., Guirado, R., Pesarico, A. P., & Nácher, J. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100460 · Cited by 25
Self-citationFluoxetine increased adult neurogenesis is mediated by 5-HT3 receptor
Olivas-Cano, I., Rodriguez-Andreu, J. M., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.137027 · Cited by 25
Self-citationKurhe, Y., & Mahesh, R. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.07.007 · Cited by 25
“The direct effect of fluoxetine on 5-HT3 receptors was confirmed by an investigation that explored the fluoxetine induced increase of Polysialic Acid Neural Cell Adhesion Molecule (PSANCAM), a molecule implicated in neuroplasticity, the effect that was antagonized by administration of 5-HT3 receptor antagonist (Varea…”
BackgroundAonurm‐Helm, A. (2010) · DSpace repository (University of Tartu) · Cited by 27
Wędzony, K., Chocyk, A., & Maćkowiak, M. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71507-x · Cited by 23
“It has been found that acute administration of ondansetron, a specific antagonist of 5-HT3 receptors, in an acute dose alleviated the increase in PSA-NCAM induced by chronic FLU administration [43].”
BackgroundInfluentialNCAM in Neuropsychiatric and Neurodegenerative Disorders
Brennaman, L. H., & Maness, P. F. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9630-z · Cited by 22
Wainwright, S. R., Barha, C. K., Hamson, D. K., Epp, J. R., Chow, C., Lieblich, S. E., Rutishauser, U. S., & Galea, L. A. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.337 · Cited by 20
“Indeed, the expression of PSA-NCAM is reduced in depressed patients, and in models of depression, and conversely enhanced by antidepressant treatment, in many regions (Sairanen et al, 2007; Varea et al, 2007; Wainwright et al, 2011).”
BackgroundFang, S., Yan, B., Wang, D., Bi, X., Zhang, Y., He, J., Xu, H., Yang, Y., Kong, J., Wu, J., et al. (2010) · Biochemistry and Cell Biology · doi:10.1139/o10-015 · Cited by 20
Dudhabhate, B. B., Awathale, S. N., Choudhary, A. G., Subhedar, N. K., & Kokare, D. M. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.052 · Cited by 19
Guirado, R., LaTerra, D., Bourguignon, M., Carceller, H., Umemori, J., Sipilä, P., Nácher, J., & Ċastrén, E. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00022 · Cited by 19
“Particularly, chronic antidepressant treatments have been reported to increase PSA-NCAM expression in different brain regions (Sairanen et al., 2007; Varea et al., 2007; Guirado et al., 2014b).”
BackgroundMethodSelf-citationMaćkowiak, M., Dudys, D., Chocyk, A., & Wędzony, K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.10.001 · Cited by 19
“A similar pattern of PSA-NCAM staining was found by Varea et al. (2005).”
BackgroundInfluentialThe effects of chronic fluoxetine treatment following injury of medial frontal cortex in mice
McAllister, B. B., Spanswick, S. C., Patel, P. P., Barneto, A. A., & Dyck, R. H. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.049 · Cited by 18
“Increased arborization could potentially be explained by the previous finding that chronic fluoxetine treatment increases expression of the polysialylated form of the neural cell adhesion molecule – a glycoprotein related to neurite outgrowth and plasticity – in cingulate cortex as well as other areas of MFC, especial…”
Olanzapine, but not haloperidol, enhances PSA-NCAM immunoreactivity in rat prefrontal cortex
Frasca, A., Fumagalli, F., ter Horst, J. P., Racagni, G., Murphy, K. J., & Riva, M. A. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009061 · Cited by 18
“The potential therapeutic relevance of our findings is strengthened by the similar effect obtained with chronic antidepressant administration (Sairanen et al., 2007; Varea et al., 2007), thus pointing to enhanced PSA-NCAM in the mPFC as a common effect of long-term treatment with psychotropic drugs.”
ResultHypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis
López‐Hidalgo, R., Ballestín, R., Vega, J., Blasco‐Ibáñez, J. M., Crespo, C., Gilabert‐Juan, J., Nácher, J., & Varea, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00075 · Cited by 17
Self-citationChang, E.-A., Beyhan, Z., Yoo, M.-S., Siripattarapravat, K., Ko, T., Lookingland, K. J., Madhukar, B. V., & Cibelli, J. B. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.092851ec · Cited by 17
Key role of 5-HT 3 receptors in the nucleus tractus solitarii in cardiovagal stress reactivity
Sévoz‐Couche, C., & Brouillard, C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.014 · Cited by 16
“It is noteworthy that 4 weeks of fluoxetine treatment, that can inhibit binding of 5-HT3 receptor antagonists (Lucchelli et al., 1995; Varea et al., 2007), can prevent behavioral responses and can partially prevent cardiovascular changes associated with chronic mild stress (Grippo et al.”
Sex-specific 24-h profile of extracellular serotonin levels in the medial prefrontal cortex
Jitsuki, S., Kimura, F., Funabashi, T., Takahashi, T., & Mitsushima, D. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.084 · Cited by 16
Reversible Morphological Remodeling of Prefrontal and Hippocampal Serotonergic Fibers by Fluoxetine
Nazzi, S., Picchi, M., Migliarini, S., Maddaloni, G., Barsotti, N., & Pasqualetti, M. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00837 · Cited by 15
Rajkumar, R., & Mahesh, R. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777256 · Cited by 15
“Fluoxetine when treated alone restored neuronal plasticity related hippocampal alterations in diabetic mice [17] and increases the expression of polysialylated form of the neural cell adhesion molecule (PSA-NCAM) and synaptophysin (through 5-HT3 receptors), which are involved in synaptic remodeling and density, respec…”
BackgroundNEUROPLASTICITY IN DEPRESSION: A NARRATIVE REVIEW WITH EVIDENCE-BASED INSIGHTS
Petra, Mudgal, S. K., Nath, S., Chaturvedi, J., Sharma, S. K., & Joshi, J. (2022) · Psychiatria Danubina · doi:10.24869/psyd.2022.390 · Cited by 14
“5HT is also linked with cell adhesion molecules which are important for neuroplasticity (Varea et al. 2007).”
BackgroundCurto, Y., Alcaide, J., Röckle, I., Hildebrandt, H., & Nácher, J. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00006 · Cited by 14
“Moreover, in human patients and in animal models, several studies have shown alterations in polySia expression and genetic associations of NCAM1 and ST8SIA2 variants with schizophrenia (Varea et al., 2007; Anney et al., 2010; Brennaman and Maness, 2010; Gilabert-Juan et al., 2011; McAuley et al., 2012; Guirado et al.,…”
ResultSelf-citationBélanger, M.-C., & Cristo, G. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024874 · Cited by 14
Maćkowiak, M., Mordalska, P., Dudys, D., Korostyński, M., Bator, E., & Wędzony, K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.030 · Cited by 12
New trends in the neurobiology and pharmacology of affective disorders
Lasoń, W., Budziszewska, B., Basta‐Kaim, A., Kubera, M., & Maes, M. H. J. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71504-4 · Cited by 12
Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome
Kirstein, M., Cambrils, A., Segarra, A., Melero, A., & Varea, E. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03659-0 · Cited by 10
Self-citationPiriform cortex alterations in the Ts65Dn model for down syndrome
Carbonell, J., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147031 · Cited by 10
Self-citationA TNR Frameshift Variant in Weimaraner Dogs with an Exercise‐Induced Paroxysmal Movement Disorder
Christen, M., Gutierrez‐Quintana, R., James, M., Faller, K. M. E., Lowrie, M. L., Rusbridge, C., Bossens, K., Mellersh, C. S., Pettitt, L., Heinonen, T., et al. (2023) · Movement Disorders · doi:10.1002/mds.29391 · Cited by 9
“although if this was the main mechanism of action we would have expected to see a slower onset of effect.(33,34) In humans, no reports of the use of fluoxetine for treating paroxysmal movement disorders could be found, but movement disorders have been reported as side effects of its use.”
BackgroundMicroglial phagocytosis and regulatory mechanisms: Key players in the pathophysiology of depression
Wang, M., Jin, G., Duan, T., Li, R., Gao, Y., Yu, M., & Xu, Y. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110383 · Cited by 8
Yamada, J., Sato, C., Konno, K., Watanabe, M., & Jinno, S. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1779-19.2019 · Cited by 8
“Chronic administration of the antidepressant FLX increased the expression of PSA-NCAM in the medial prefrontal cortex of adult rats (Varea et al., 2007).”
BackgroundLópez‐Hidalgo, R., Ballestín, R., Lorenzo, L., Sánchez-Martí, S., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105679 · Cited by 6
“We analysed the intensity of the immunohistochemical staining for BDNF and PSA-NCAM in the different subregions and layers of the hippocampus after the treatment by using a previously described methodology (Varea et al., 2007).”
Self-citationYang, H., Chen, Y., Tao, Q., Shi, W., Tian, Y. Q., Wei, Y., Li, S., Zhang, Y., Han, S., & Cheng, J. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111052 · Cited by 6
Long-Term Adaptive Changes Induced by Antidepressants: From Conventional to Novel Therapies
Mnie‐Filali, O., Abrial, E., Lambás‐Señas, L., & Haddjeri, N. (2013) · InTech eBooks · doi:10.5772/54553 · Cited by 6
“In accordance, a recent study revealed lower expression of synaptic function-related genes in the dorsolateral PFC of MDD subjects and a corresponding lower number of synapses [130].”
BackgroundInfluentialVillarroya, O., Ballestín, R., López‐Hidalgo, R., Mulet, M., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., Gilabert‐Juan, J., & Varea, E. (2018) · PubMed · doi:10.14670/hh-11-894 · Cited by 6
“In order to analyse the intensity of the immunostaining we used a previously described methodology (Varea et al., 2007a).”
BackgroundMethodSelf-citationDisturbances in the expression Of neuronal cell adhesion proteins NCAM. Clinical aspects
Chekhonin, V. P., Shepeleva, I. I., & Gurina, O. I. (2008) · Neurochemical Journal · doi:10.1134/s1819712408040028 · Cited by 5
Highet, B., Wiseman, J. A., Mein, H., Parker, R., Ryan, B., Turner, C. P., Yu, J. H., Singh‐Bains, M. K., Liu, P., Dragunow, M., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220986 · Cited by 4
Carceller, H., Guirado, R., & Nácher, J. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24832 · Cited by 4
Self-citationOndansetron blocks fluoxetine effects in immature neurons in the adult rat piriform cortex layer II
Recatalá, M., Hidalgo, P., Nácher, J., Blasco‐Ibáñez, J. M., Crespo, C., & Varea, E. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.138099 · Cited by 2
Self-citationNeurotrophins and neuronal plasticity in the action of antidepressants and morphine
Sairanen, M. (2007) · Helda - University of Helsinki Institutional Repository · Cited by 2
Neurobiologic correlates of depression: illustration of challenges in bench-to-bedside translation
Jones, B. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820007-0.00037-4 · Cited by 1
Cerdá, H. C. (2019) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 1
Stil, A. (2011) · theses.fr (ABES) · doi:10.70675/0a615ab8z65c9z451az9b08zc423d6cb7d77 · Cited by 1
Metadata
- Authors
- Varea, E., Blasco-Ibáñez, J. M., Gómez-Climent, M. Á., Castillo-Gómez, E., Crespo, C., Martínez-Guijarro, F. J., & Nácher, J.
- Affiliations
- Universitat de València (ES)
- Corresponding author
- Nácher, Juan
- Venue
- Neuropsychopharmacology
- Published
- 2006-08-09
- Volume
- 32
- Issue
- 4
- Pages
- 803-812
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2051045604
- Cited by
- 96
- References
- 66
- Citations by year
- 2025: 1 · 2024: 5 · 2023: 2 · 2022: 3 · 2020: 3 · 2019: 7 · 2018: 2 · 2017: 2 · 2016: 6 · 2015: 5 · 2014: 3 · 2013: 8 · 2012: 7
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministerio de Economía y Competitividad
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- fluoxetine, PSA-NCAM, CD56, medial prefrontal cortex, depression, serotonin, 5-HT3 receptor, ondansetron, antidepressant mechanism, neuropil
- MeSH terms
- Analysis of Variance, Animals, Cell Count, Fluorescent Antibody Technique, Fluoxetine, Gene Expression Regulation, Male, Neurons, Receptors, Serotonin, Sialic Acids, Rats, Sprague-Dawley, Prefrontal Cortex, Antidepressive Agents, Second-Generation, Neural Cell Adhesion Molecule L1, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.